The specificity of the assay with the AQP461–70-nanoimmunosensor was tested with the receiver operating characteristic (ROC) curve to analyse the accuracy in distinguishing the healthy volunteers and MS patients from NMOSD AQP4-Ab-positive patients. The gene discussed is AQP4; the disease is myeloid sarcoma.